These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 15934253

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Horvath-Ungerboeck C, Thoday KL, Shaw DJ, van den Broek AH.
    Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens.
    Zonneveld IM, De Rie MA, Beljaards RC, Van Der Rhee HJ, Wuite J, Zeegelaar J, Bos JD.
    Br J Dermatol; 1996 Sep; 135 Suppl 48():15-20. PubMed ID: 8881899
    [Abstract] [Full Text] [Related]

  • 47. A double-blinded, randomized, controlled, crossover evaluation of a zinc methionine supplement as an adjunctive treatment for canine atopic dermatitis.
    McFadden RA, Heinrich NA, Haarstad AC, Tomlinson DJ.
    Vet Dermatol; 2017 Dec; 28(6):569-e138. PubMed ID: 28736909
    [Abstract] [Full Text] [Related]

  • 48. Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
    White AG, Santoro D, Ahrens K, Marsella R.
    Vet Immunol Immunopathol; 2018 Mar; 197():93-101. PubMed ID: 29475513
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.
    Olivry T, Mueller R, Nuttall T, Favrot C, Prélaud P, International Task Force on Canine Atopic Dermatitis.
    Vet Dermatol; 2008 Jun; 19(3):115-9. PubMed ID: 18477326
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled trial.
    Takahashi J, Kanda S, Imanishi I, Hisano T, Fukamachi T, Taguchi N, Momiyama S, Nishiyama S, Motegi T, Iyori K.
    Vet Dermatol; 2021 Apr; 32(2):119-e25. PubMed ID: 33185330
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA.
    Souza CP, Rosychuk RAW, Contreras ET, Schissler JR, Simpson AC.
    Vet Dermatol; 2018 Dec; 29(6):489-e164. PubMed ID: 30141223
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.